Renal interleukin-6 production in normotensive and hypertensive rats. 1994

A Nakamura, and T Kohsaka, and E J Johns
Department of Physiology, University of Birmingham, UK.

OBJECTIVE To determine whether renal interleukin-6 was produced constitutively under the normal physiological conditions and to evaluate the influence of hypertension development on interleukin-6 production in two different hypertensive models, the spontaneously hypertensive rat (SHR) and the two-kidney, one clip (2-K,1C) hypertensive rat. METHODS In a chronic study, Wistar rats and SHR, aged 4, 5, 7 and 9 weeks, and 2-K,1C Goldblatt hypertensive rats, at 2 and 4 weeks after applying the clip, were anaesthetized, their blood pressures were measured and the kidneys were collected and renal interleukin-6 production estimated. METHODS The rats were lightly anaesthetized with halothane and prepared for blood pressure measurement via a carotid artery cannula. Interleukin-6 production was estimated from the interleukin-6 messenger RNA (mRNA) present in the kidney tissue. The mRNA species (interleukin-6, beta-actin and renin) were measured by densitometric analysis of the autoradiographs following Northern blot hybridization. RESULTS The blood pressure was approximately 100 mmHg at all ages in the Wistar rats, but rose from 101 +/- 3 mmHg at age 4 weeks to 154 +/- 2 mmHg at age 9 weeks in the SHR (means +/- SEM, P < 0.01). Constitutive production of renal interleukin-6 could not be detected in either the Wistar rats or the SHR. In 2-K,1C rats the blood pressure was increased significantly at 2 and 4 weeks after clipping to 129 +/- 3 and 140 +/- 4 mmHg (means +/- SEM, both P < 0.01), respectively, and the renal renin mRNA concentration was increased significantly in the clipped and decreased in the non-clipped kidneys at 2 and 4 weeks after clipping. The renal interleukin-6 mRNA could not be measured in either clipped or non-clipped kidneys at either 2 or 4 weeks after clipping. CONCLUSIONS These findings demonstrate that renal interleukin-6 was not produced constitutively under normal physiological conditions. Moreover, in spite of the development of hypertension from two causes, genetic and renin-dependent, renal interleukin-6 was not expressed even though there is a deficit in immunological function in the SHR and damage to the renal tissue of the 2-K,1C rats.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

A Nakamura, and T Kohsaka, and E J Johns
January 1982, Life sciences,
A Nakamura, and T Kohsaka, and E J Johns
December 1968, The Australian journal of experimental biology and medical science,
A Nakamura, and T Kohsaka, and E J Johns
April 1993, Behavioural brain research,
A Nakamura, and T Kohsaka, and E J Johns
December 1998, The American journal of physiology,
A Nakamura, and T Kohsaka, and E J Johns
December 1998, Circulation,
A Nakamura, and T Kohsaka, and E J Johns
January 1985, Renal physiology,
A Nakamura, and T Kohsaka, and E J Johns
March 1998, IEEE transactions on bio-medical engineering,
A Nakamura, and T Kohsaka, and E J Johns
May 1984, Kidney international,
A Nakamura, and T Kohsaka, and E J Johns
January 1974, Archives internationales de physiologie et de biochimie,
Copied contents to your clipboard!